Craig Burton | Executive Director
Biosimilars Council

Craig Burton, Executive Director, Biosimilars Council

Craig Burton is Vice President of Policy for the Association for Accessible Medicines where he leads policy development. With nearly 20 years of Federal health policy experience, Craig has served in key roles at the center of a range of pressing health care debates. Prior to joining AAM, Craig was a Director at Avalere Health, where he helped clients anticipate and plan for the impact of change stemming from legislative, regulatory, or other market dynamics, with particular attention to crafting policy options that are closely tied to a client’s specific business needs and strategy. Craig also established and directed the health policy and government relations efforts for two biopharmaceutical companies. Craig served as Deputy Assistant Secretary for Legislation in the U.S. Department of Health and Human Services. In this role, he advised the Secretary, senior Department leaders and White House officials on legislative strategy to achieve key priorities. Craig also served in the Senate, where he was Health Policy Advisor to Senate Majority Leader Bill Frist, M.D. and professional staff on the U.S. Senate Committee on Health, Education, Labor and Pensions.


Festival of Biologics Day 2 @ 11:40

An overview of biosimilar adoption and changes to the political/policy landscape

last published: 31/Jan/23 09:55 GMT
last published: 31/Jan/23 09:55 GMT

back to speakers